To carry out special maternal and child health (MCH) projects of regional and national significance; to conduct training and research; to conduct genetic disease testing, counseling, and information development and dissemination programs; for the screening of newborns for sickle cell anemia, and other

credit: Photo credit: Alamy

genetic disorders; and to support comprehensive hemophilia diagnostic and treatment centers.

These grants are funded with a set-aside from the MCH Block grant program.

SPRANS grants are funded with 15 percent of the Block Grant appropriation of up to $600 million.

When the appropriation exceeds $600 million, 12.75 percent of the amount over $600 million is set aside for the Community Integrated Service Systems grants.

15 percent of the balance remaining over $600 million is also for SPRANS.

The CISS program is to develop and expand the following: (1) Home visitation; (2) increased participation of obstetricians and pediatricians; (3) integrated service delivery systems; (4) maternal and child health centers for women and infants, under the direction of a not-for-profit hospital; (5) services for rural populations; and (6) integrated state and community service systems for children and youth with special health care needs.

First funded in 2004, the Heritable Disorders Program is established to improve the ability of States to provide newborn and child screening for heritable disorders and affect the lives of all of the nation?s infants and children.

Newborn and child screening occur at intervals across the life span of every child.

Newborn screening universally provides early identification and follow-up for treatment of infants affected by certain genetic, metabolic, hormonal and/or functional conditions.

It is expected that newborn and child screening will expand as the capacity to screen for genetic and congenital conditions expands.

Selected Recipients for this Program

Not Applicable.

Uses and Use Restrictions

Training grants are made to institutions of higher learning for training personnel for health care and related services for mothers and children.

Research grants are for the purpose of research activities which show promise of a substantial contribution to the advancement of maternal and child health services.

Genetic grants are for genetic disease testing, counseling and information development and dissemination.

Hemophilia grants are for the support of centers which provide hemophilia diagnostic and treatment services.

Sickle cell disease grants are made to support follow up for infants with sickle cell identified through newborn screening.

Heritable Disorders grants are made to improve the ability of States to provide newborn and child screening for heritable disorders, coordinate services and long-term follow-up for newborns and children identified with a condition through newborn screening, and to provide newborn screening education resources to patients, parents, and families.

Environmental health grants are made to decrease maternal and child morbidity and mortality associated with pre-and post-natal environmental exposures.

Other special project grants are designed to support activities of a demonstration nature which are designed to improve services for mothers and children. Restricted Uses: Indirect costs that are allowed for administrative costs incurred as a result of the training grants project, are limited to 8 percent of direct costs.

Eligibility Requirements

Applicant Eligibility

Training grants may be made to public or private nonprofit institutions of higher learning.

Research grants may be made to public or private nonprofit institutions of higher learning and public or private nonprofit private agencies and organizations engaged in research or in Maternal and Child Health (MCH) or Children with Special Health Care Needs (CSHCN) programs.

Any public or private entity is eligible for hemophilia, genetics, and environmental health grants and other special project grants, including CISS.

Eligible entities for the Heritable Disorders Program include a State or a political subdivision of a State; a consortium of 2 or more States of political subdivisions of States; a territory; a health facility or program operated by or pursuant to a contract with or grant from the Indian Health Service; or any other entity with appropriate expertise in newborn screening, as determined by the Secretary.

Beneficiary Eligibility

For training grants: (1) Trainees in the health professions related to MCH; and (2) mothers and children who receive services through training programs. For research grants: public or private nonprofit agencies and organizations engaged in research in MCH or CSHCN programs. For hemophilia, sickle cell, thalassemia genetics, or environmental health, and other special projects: (1) Public or private agencies, organizations and institutions; and (2) mothers and children, and persons with genetic conditions including hemophilia (any age), who receive services through the programs.

Credentials/Documentation

Applicants should review the individual HRSA notice of funding opportunity issued under this CFDA program for any required proof or certifications which must be submitted prior to or simultaneous with submission of an application package. 2 CFR 200, Subpart E - Cost Principles applies to this program.

Aplication and Award Process

Preapplication Coordination

Preapplication coordination is required.

Environmental impact information is not required for this program.

This program is excluded from coverage under E.O.

12372.

Application Procedures

2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. HRSA requires all applicants to apply electronically through Grants.gov. All qualified applications will be forwarded to an objective review committee. Based on the advice of the objective review committee, the HRSA program official with delegated authority is responsible for final selection and funding decisions.

Award Procedures

Notification is made in writing by a Notice of Award.

Deadlines

Contact the headquarters or regional office, as appropriate, for application deadlines.

Authorization

Social Security Act, Title V, Section 502(a)(1) and (b)(1), as amended; 42 U.S.C. 702.; Section 1109, 1111 and 1112 of the Public Health Service Act and Section 399T of the Public Health Service Act.

Range of Approval/Disapproval Time

From 3 to 6 months.

Appeals

Not Applicable.

Renewals

After initial award, projects may be renewed annually up to the limit of the project period upon the submission and approval of a satisfactory continuation application.

Assistance Considerations

Formula and Matching Requirements

This program has no statutory formula. Matching Requirements: Opportunities may include matching requirements. Please refer to the notice of funding opportunity. This program does not have MOE requirements.

Length and Time Phasing of Assistance

Awards are made on an annual basis for the duration of the grant period, and payments are made through an Electronic Transfer System or Cash Demand System. See the following for information on how assistance is awarded/released: Grantees draw down funds, as necessary, from the Payment Management System (PMS). PMS is the centralized web based payment system for HHS awards.

Post Assistance Requirements

Reports

Please refer to 'progress reports' information below.

Cash reports are not applicable.

The awardee will be required to submit performance and progress reports as well as status-federal financial reports (see the program announcement and notice of award for details for each required report).

The awardee must submit a quarterly electronic Federal Financial Report (FFR) Cash Transaction Report via the Payment Management System within 30 days of the end of each calendar quarter.

A Federal Financial Report (SF-425) according to the following schedule: http://www.hrsa.gov/grants/manage/technicalassistance/federalfinancialreport/ffrschedule.pdf.

A final report is due within 90 days after the project period ends.

If applicable, the awardee must submit a Tangible Personal Property Report (SF-428) and any related forms within 90 days after the project period ends.

New awards (?Type 1?) issued under this notice of funding opportunity are subject to the reporting requirements of the Federal Funding Accountability and Transparency Act (FFATA) of 2006 (Pub.

L.

109?282), as amended by section 6202 of Public Law 110?252, and implemented by 2 CFR Part 170.

Grant and cooperative agreement recipients must report information for each first-tier subaward of $25,000 or more in federal funds and executive total compensation for the recipient?s and subrecipient?s five most highly compensated executives as outlined in Appendix A to 2 CFR Part 170 (FFATA details are available online at http://www.hrsa.gov/grants/ffata.html).

Competing continuation awardees, etc.

may be subject to this requirement and will be so notified in the Notice of Award.

Expenditure reports are not applicable.

Refer to the notice of funding opportunity for further information.

Audits

In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503.

Records

Grantees are required to maintain grant accounting records for 3 years after the date they submit the Federal Financial Report (FFR). If any litigation, claim, negotiation, audit, or other action involving the award has been started before the expiration of the 3-year period, the records shall be retained until completion of the action and resolution of all issues which arise from it, or until the end of the regular 3-year period, whichever is later.

Financial Information

Account Identification

75-0354-0-1-550.

Obigations

(Project Grants) FY 16 $133,938,299; FY 17 est $157,449,942; and FY 18 est $81,146,575 - FY2017 includes $20M for Zika response.

Range and Average of Financial Assistance

$3,419 to $3,996,711; $267,663.

Regulations, Guidelines, and Literature

This program is subject to the provisions of 45 CFR Part 75 State, local and tribal governments, institutions of higher education, hospitals, other nonprofit organizations and commercial organizations, as applicable. 42 CFR Part 51a Project Grants for Maternal and Child and Health. HRSA awards are subject to the requirements of the HHS Grants Policy Statement (HHS GPS) that are applicable based on recipient type and purpose of award. The HHS GPS is available at http://www.hrsa.gov/grants.

Information Contacts

Regional or Local Office

See Regional Agency Offices. Associate Administrator for Maternal and Child Health, Health Resources and Services Administration, Department of Health and Human Services, Room 18W37, 5600 Fishers Lane, Rockville, MD 20857. Telephone: (301) 443-2170.

Headquarters Office

Associate Administrator for Maternal and Child Health, 5600 Fishers Lane, Room 18W37, Rockville, Maryland 20857 Phone: (301) 443-2170.

Criteria for Selecting Proposals

General criteria are described in Program Regulations 45 CFR 51, and specific criteria are included in the program guidance materials provided with application kits. Contact Central Office for details.